< 1 minute read
Dec. 20, 2021
DS96432529: a CDK8 Kinase Inhibitor Intended as a Bone Anabolic Agent
DS96432529
oral CDK8 kinase inhibitor effective in ovariectomized rat model CDK8 identified as MoA after screen Bioorganic & Medicinal Chemistry Letters Daiichi Sankyo Co. Ltd.
Loading...
